These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6114837)

  • 21. Estimation of the systemic availability and other pharmacokinetic parameters of naltrexone in man after acute and chronic oral administration.
    Kogan MJ; Verebey K; Mule SJ
    Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):29-34. PubMed ID: 905632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and identification of a new metabolite of naltrexone in human blood and urine.
    Verebely K; Chedekel MA; Mule SJ; Rosenthal D
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):67-84. PubMed ID: 1188187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of naltrexone and 6-beta-naltrexol in human plasma following implantation of naltrexone pellets using gas chromatography-mass spectrometry.
    Toennes SW; Kauert GF; Grüsser SM; Jäkel W; Partecke G
    J Pharm Biomed Anal; 2004 Apr; 35(1):169-76. PubMed ID: 15030891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfer of naltrexone and its metabolite 6,beta-naltrexol into human milk.
    Chan CF; Page-Sharp M; Kristensen JH; O'Neil G; Ilett KF
    J Hum Lact; 2004 Aug; 20(3):322-6. PubMed ID: 15296587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of a naltrexone sustained-release preparation.
    Chiang CN; Hollister LE; Kishimoto A; Barnett G
    Clin Pharmacol Ther; 1984 Nov; 36(5):704-8. PubMed ID: 6488691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A gas-liquid chromatographic method for the determination of naltrexone and beta-naltrexol in human urine.
    Verebely K; Mulé SJ; Jukofsky D
    J Chromatogr; 1975 Aug; 111(1):141-8. PubMed ID: 239958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
    Dunbar JL; Turncliff RZ; Dong Q; Silverman BL; Ehrich EW; Lasseter KC
    Alcohol Clin Exp Res; 2006 Mar; 30(3):480-90. PubMed ID: 16499489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naltrexone biotransformation and incidence of subjective side effects: a preliminary study.
    King AC; Volpicelli JR; Gunduz M; O'Brien CP; Kreek MJ
    Alcohol Clin Exp Res; 1997 Aug; 21(5):906-9. PubMed ID: 9267542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition of (15,16-3H)naltrexone in the central nervous system of the rat.
    Misra AL; Bloch R; Vardy J; Mulé SJ; Verebely K
    Drug Metab Dispos; 1976; 4(3):276-80. PubMed ID: 6233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic reduction of naltrexone II. In vitro studies using liver from guinea pig, monkey and rat.
    Malspeis L; Ludden TM; Bathala MS; Morrison BE; Feller DR; Reuning RH
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):393-406. PubMed ID: 822483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing of drug delivery systems for use in the treatment of narcotic addiction.
    Reuning RH; Malspeis L; Frank S; Notari RE
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):43-5. PubMed ID: 827709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The disposition and metabolism of a hypnotic benzodiazepine, quazepam, in the hamster and mouse.
    Hilbert J; Pramanik B; Symchowicz S; Zampaglione N
    Drug Metab Dispos; 1984; 12(4):452-9. PubMed ID: 6148212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
    Sauer JM; Bao J; Smith RL; Kuester RK; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposition and metabolism of finasteride in dogs.
    Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
    Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The stimulatory effect of morphine on reduction of naltrexone to 6 alpha-naltrexol in the guinea pig.
    Roerig SC; Fujimoto JM; Wang RI
    Drug Metab Dispos; 1980; 8(5):295-9. PubMed ID: 6107224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers.
    McCaul ME; Wand GS; Rohde C; Lee SM
    Alcohol Clin Exp Res; 2000 Sep; 24(9):1385-91. PubMed ID: 11003204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of naltrexone, a long-acting opiate antagonist.
    Crabtree BL
    Clin Pharm; 1984; 3(3):273-80. PubMed ID: 6329589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disposition and metabolism of radiolabeled casopitant in humans.
    Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
    Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.